Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Get to know Erica Yount of Modera Wealth Management, LLC
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Tom Orecchio, CFA, CFP - Chief Executive Officer - Modera Wealth Management
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Uncovering both long and short opportunities through in-depth original research|Mr. Obus, Partner,Wynnefield Capital Inc.
00:10:00
High-Purity Manganese Sulfate Monohydrate for North American EV Sector
00:10:00
Introducing Tracy White: Syverson Strege Team | Tracy White - Receptionist of Syverson Strege
00:10:00
Downing Estate Drilling Celebrates 80-Year Legacy with Boart Longyear
00:10:00
Terrain Minerals Targets Multi-Staged Gold & Gallium Growth with Smokebush Drilling, WA Gov-Funded Metallurgy, and New Copper-Gold Expansion|Justin Virgin,Executive Director
00:00:00
Alan Beasley, CEO, Hydroponics Company Ltd
00:10:00
Daugava on Mister Spex’s Expansion: From Germany to Europe’s Top Online Eyewear Brand | Dirk Graber , CEO, Mister Spex SE.
00:00:00
Cello Health 'making good headway' with decent organic growth - Mark Scott, chief executive of Cello Health plc
00:10:00
A research and development company and license its current and future technologies|Mr Maurie Stang,Non Executive Deputy Chairman,Vectus Biosystems Ltd
00:10:00
Heavybit is an early-stage venture capital firm and the premiere investor|James Lindenbaum,General Partner,Heavybit
00:10:00
New Pacific Metals: Advancing Silver Exploration and Development in Bolivia
00:10:00
Economic Review and Upcoming Data with Rob McDougle | Rob McDougle, Vice-President, Zhang Financial.